Celldex Therapeutics, Inc. Repayments of Other Long-term Debt
Celldex Therapeutics, Inc. (CLDX) reported Repayments of Other Long-term Debt of $472.00 thousand for the 12-month period ending 2013-12-31, per its 10-K/A filed 2016-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2016-02-25
- Celldex Therapeutics, Inc. repayments of other long-term debt for the quarter ending 2013-12-31 was $428.00K, a 2957.14% increase year-over-year.
- Celldex Therapeutics, Inc. repayments of other long-term debt for the quarter ending 2013-09-30 was $15.00K, a 25.00% increase year-over-year.
- Celldex Therapeutics, Inc. repayments of other long-term debt for the quarter ending 2013-06-30 was $14.00K, a 0.00% change year-over-year.
- Celldex Therapeutics, Inc. repayments of other long-term debt for the quarter ending 2013-03-31 was $15.00K, a 0.00% change year-over-year.
- Celldex Therapeutics, Inc. repayments of other long-term debt for fiscal 2013 was $472.00K, a 758.18% increase from fiscal 2012.
- Celldex Therapeutics, Inc. repayments of other long-term debt for fiscal 2012 was $55.00K, a 36.05% decline from fiscal 2011.
- Celldex Therapeutics, Inc. repayments of other long-term debt for fiscal 2011 was $86.00K, a 56.35% decline from fiscal 2010.
- Celldex Therapeutics, Inc. repayments of other long-term debt for fiscal 2010 was $197.00K, a 11.93% increase from fiscal 2009.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $428.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | $443.00K derived: sum of 2 quarters · filed 2016-02-25 | $457.00K derived: sum of 3 quarters · filed 2016-02-25 | $472.00K 10-K/A · filed 2016-02-25 |
| 2013-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $29.00K derived: sum of 2 quarters · filed 2014-11-05 | $44.00K 10-Q · filed 2014-11-05 | $58.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $29.00K 10-Q · filed 2014-08-07 | $43.00K derived: sum of 3 quarters · filed 2015-02-24 | $55.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $15.00K 10-Q · filed 2014-05-01 | $29.00K derived: sum of 2 quarters · filed 2015-02-24 | $41.00K derived: sum of 3 quarters · filed 2015-02-24 | $55.00K derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $26.00K derived: sum of 2 quarters · filed 2015-02-24 | $40.00K derived: sum of 3 quarters · filed 2015-02-24 | $55.00K 10-K · filed 2015-02-24 |
| 2012-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $26.00K derived: sum of 2 quarters · filed 2013-11-08 | $41.00K 10-Q · filed 2013-11-08 | $55.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $29.00K 10-Q · filed 2013-08-06 | $43.00K derived: sum of 3 quarters · filed 2014-03-03 | $57.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $15.00K 10-Q · filed 2013-05-03 | $29.00K derived: sum of 2 quarters · filed 2014-03-03 | $43.00K derived: sum of 3 quarters · filed 2014-03-03 | $55.00K derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $28.00K derived: sum of 2 quarters · filed 2014-03-03 | $40.00K derived: sum of 3 quarters · filed 2014-03-03 | $86.00K 10-K · filed 2014-03-03 |
| 2011-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $26.00K derived: sum of 2 quarters · filed 2012-11-02 | $72.00K 10-Q · filed 2012-11-02 | $124.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $58.00K 10-Q · filed 2012-08-09 | $110.00K derived: sum of 3 quarters · filed 2013-03-08 | $161.00K derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | $46.00K 10-Q · filed 2012-05-04 | $98.00K derived: sum of 2 quarters · filed 2013-03-08 | $149.00K derived: sum of 3 quarters · filed 2013-03-08 | |
| 2010-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $103.00K derived: sum of 2 quarters · filed 2013-03-08 | $197.00K 10-K · filed 2013-03-08 | |
| 2010-09-30 | $51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $145.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $94.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $176.00K 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |